Extended-Spectrum Beta-Lactamase Escherichia Coli-Associated Acute Cholangitis: Uncommon Patient Characteristics and Clinical Implications

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Mar 22

PMID 38516487

Authors

Somin Lee

Abeer Qasim

Ahmed Alemam

Misbahuddin Khaja

Anil Dev

Affiliations

Soon will be listed here.

Abstract

Acute cholangitis is a potentially life-threatening condition caused by an infection of the biliary tract resulting from biliary obstruction. This case report highlights an unusual presentation of acute cholangitis in an elderly patient characterized by the presence of extended-spectrum beta-lactamase-producing We aim to emphasize the significance of recognizing diverse clinical manifestations in the elderly population to enhance timely diagnosis and appropriate management. The case highlights the importance of better understanding patient risk factors for potential causative organisms and their susceptibility to selecting proper antibiotics and improving clinical outcomes.

References

Miura F, Okamoto K, Takada T, Strasberg S, Asbun H, Pitt H . Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2017; 25(1):31-40. DOI: 10.1002/jhbp.509. View

Buckman S, Mazuski J . Review of the Tokyo Guidelines 2018: Antimicrobial Therapy for Acute Cholangitis and Cholecystitis. JAMA Surg. 2019; 154(9):873-874. DOI: 10.1001/jamasurg.2019.2169. View

Kang C, Cheong H, Chung D, Peck K, Song J, Oh M . Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Eur J Clin Microbiol Infect Dis. 2007; 27(1):85-8. DOI: 10.1007/s10096-007-0401-6. View

Kruis T, Guse-Jaschuck S, Siegmund B, Adam T, Epple H . Use of microbiological and patient data for choice of empirical antibiotic therapy in acute cholangitis. BMC Gastroenterol. 2020; 20(1):65. PMC: 7066745. DOI: 10.1186/s12876-020-01201-6. View

Sokal A, Sauvanet A, Fantin B, de Lastours V . Acute cholangitis: Diagnosis and management. J Visc Surg. 2019; 156(6):515-525. DOI: 10.1016/j.jviscsurg.2019.05.007. View

Goo J, Seong M, Shim Y, Lee H, Han J, Han J . Extended Spectrum-β-Lactamase or Carbapenemase Producing Bacteria Isolated from Patients with Acute Cholangitis. Clin Endosc. 2012; 45(2):155-60. PMC: 3401620. DOI: 10.5946/ce.2012.45.2.155. View

Rodriguez-Bano J, Navarro M, Romero L, Martinez-Martinez L, Muniain M, Perea E . Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004; 42(3):1089-94. PMC: 356843. DOI: 10.1128/JCM.42.3.1089-1094.2004. View

Harris P, Tambyah P, Lye D, Mo Y, Lee T, Yilmaz M . Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. JAMA. 2018; 320(10):984-994. PMC: 6143100. DOI: 10.1001/jama.2018.12163. View

Gomi H, Takada T, Hwang T, Akazawa K, Mori R, Endo I . Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitis. J Hepatobiliary Pancreat Sci. 2017; 24(6):310-318. DOI: 10.1002/jhbp.452. View

10.

Shenoy S, Shenoy S, Gopal S, Tantry B, Baliga S, Jain A . Clinicomicrobiological analysis of patients with cholangitis. Indian J Med Microbiol. 2014; 32(2):157-60. DOI: 10.4103/0255-0857.129802. View

11.

Takada T, Strasberg S, Solomkin J, Pitt H, Gomi H, Yoshida M . TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013; 20(1):1-7. DOI: 10.1007/s00534-012-0566-y. View

12.

Sulzer J, Ocuin L . Cholangitis: Causes, Diagnosis, and Management. Surg Clin North Am. 2019; 99(2):175-184. DOI: 10.1016/j.suc.2018.11.002. View